NCT00417079 XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00416832 Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00416533 Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00414414 A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection Status WITHDRAWN Phase PHASE3
NCT00413920 Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients Status COMPLETED Phase PHASE3
NCT00411528 Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00410657 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT00408005 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Status COMPLETED Phase PHASE3
NCT00406978 Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00405756 A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. Status COMPLETED Phase PHASE3
NCT00398554 Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00390793 Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. Status COMPLETED Phase PHASE2
NCT00389818 Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00388635 Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients. Status COMPLETED Phase PHASE1/PHASE2
NCT00388362 Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease Status COMPLETED Phase PHASE2
NCT00385827 A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC) Status TERMINATED Phase PHASE2
NCT00381680 Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE3
NCT00379041 Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00376961 S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma Status COMPLETED Phase PHASE2